Alkermes outlines $1.73B–$1.84B 2026 revenue target as Avadel acquisition expands commercial reach
Q4 2025 earnings call recap: 2026 revenue/EBITDA guidance, Avadel-LUMRYZ integration, pipeline catalysts, and key risks—read now.
With prediction markets booming, so have concerns about insider trading. Now, Kalshi has disclosed its first public actions against accounts suspected of trading on confidential information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results